NCT00128544View on ClinicalTrials.gov

Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B

PHASE2CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Hepatitis B

Interventions

DRUG

telbivudine

DRUG

valtorcitabine

Trial Locations (3)

Unknown

Pokfulam

Auckland

Singapore

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Novartis

INDUSTRY